Home > Request Information
Title:
Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T Cell Engager
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh